Read the article in full featured on pharmaphorum, where IQVIA leaders share their perspectives on how oncology is evolving toward earlier-stage, patient-centric strategies with curative intent.

Hear from:

• Gijsbert Veerman, Chief Operating Officer, IQVIA Biotech
• José Luis García, Senior Medical Strategy Director, Oncology Center of Excellence, IQVIA
• John Cochran, Chief Medical Officer, IQVIA Laboratories

This article explores key insights and the trends that are redefining oncology research and patient care, including:

• The growing impact of antibody-drug conjugates
• Advances in biomarker-driven precision medicine
• Innovative trial designs optimizing outcomes across tumor types